REFERENCES
- Diener-West M, Earle J D, Fine S L, et al. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report no. 18. Arch Ophthalmol 2001; 119: 969–982
- Kertes P J, Johnson J C, Peyman G A. Internal resection of posterior uveal melanomas. Br J Ophthalmol 1998; 82: 1147–1153
- Melia B M, Abramson D H, Albert D M, et al. Collaborative Ocular Melanoma Study Group. Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium melanoma. I. Visual acuity after 3 years. COMS report no. 16. Ophthalmology 2001; 108: 348–366
- Shields C L, Naseripour M, Cater J, et al. Plaque radiotherapy for large posterior uveal melanomas (> or = 8 mm thick) in 354 consecutive patients. Ophthalmology 2002; 109: 1838–1849
- Puusaari I, Heikkone J, Kivela T. Ocular complications after iodine brachytherapy for large uveal melanomas. Ophthalmology 2004; 111: 1768–1777
- Wilensky J T. Blood-induced secondary glaucomas. Ann Ophthalmol 1979; 11(11)1659–1662
- Brucker A J, Michels R G, Green W R. Pars plana vitrectomy in the management of blood-induced glaucoma with vitreous hemorrhage. Ann Ophthalmol 1978; 10(10)1427–1437
- Singh H, Grand M G. Treatment of blood-induced glaucoma by trans pars plana vitrectomy. Retina 1981; 1(3)255–257
- Abu el-Asrar A M, al-Obeidan S A. Pars plana vitrectomy in the management of ghost cell glaucoma. Int Ophthalmol 1995; 19: 121–124
- Campell D G. Ghost cell glaucoma following trauma. Ophthalmology 1981; 88: 1151–1158
- Coles W H. Traumatic hyphema: an analysis of 235 cases. South Med J 1968; 61: 813–6
- Graul T A, Ruttum M S, Lloyd M A, et al. Trabeculectomy for traumatic hyphema with increased intraocular pressure. Am J Ophthalmol 1994; 117: 155–159
- Jampol L M, Moy C S, Murray T G, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 2002; 129: 199–204
- Pe'er J, Stefani F H, Seregard S, et al. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study. Br J Ophthalmol 2001; 85: 1208–1212